Saha S, Batten T F, McWilliam P N
Institute for Cardiovascular Research, School of Medicine, University of Leeds, Leeds, United Kingdom.
Synapse. 1999 Sep 1;33(3):192-206. doi: 10.1002/(SICI)1098-2396(19990901)33:3<192::AID-SYN4>3.0.CO;2-K.
Postembedding immunogold labeling methods applied to ultrathin and semithin sections of cat dorsomedial medulla showed that neuronal perikarya, dendrites, myelinated and nonmyelinated axons, and axon terminals in the nucleus tractus solitarii contain glycine immunoreactivity. Light microscopic observations on semithin sections revealed that these immunoreactive structures were unevenly distributed throughout the entire nucleus. At the electron microscopic level, synaptic terminals with high levels of glycine-immunoreactivity, assumed to represent those releasing glycine as a neurotransmitter, were discriminated from terminals containing low, probably metabolic levels of glycine-immunoreactivity, by a quantitative analysis method. This compared the immunolabeling of randomly sampled terminals with a reference level of labeling derived from sampling the perikarya of dorsal vagal neurones. The vast majority of these "glycinergic" terminals contained pleomorphic vesicles, formed symmetrical synaptic active zones, and targeted dendrites. They appeared to be more numerous in areas of the nucleus tractus solitarii adjoining the tractus solitarius, but rather scarce caudally, medially, ventrally, and in the dorsal motor vagal nucleus. In a random analysis of the entire nucleus tractus solitarii, 26.2% of sampled terminals were found to qualify as glycine-immunoreactive. In contrast, boutons immunoreactive for gamma-aminobutyric acid (GABA) were more evenly distributed throughout the dorsal vagal complex and accounted for 33.7% of the synaptic terminals sampled. A comparison of serial ultrathin sections suggested three subpopulations of synaptic terminals: one containing high levels of both GABA- and glycine-immunoreactivities (21% of all terminals sampled), one containing only GABA-immunoreactivity (12.7%), and relatively few terminals (5.2%) that were immunoreactive for glycine alone. These results were confirmed by dual labeling of sections using gold particles of different sizes. This study reports the first analysis of the ultrastructure of glycinergic nerve terminals in the cat dorsal vagal complex, and the pattern of coexistence of glycine and GABA observed provides an anatomical explanation for our previously reported inhibitory effects of glycine and GABA on neurones with cardiovascular and respiratory functions in the nucleus tractus solitarii.
应用于猫延髓背内侧超薄和半薄切片的包埋后免疫金标记方法显示,孤束核中的神经元胞体、树突、有髓和无髓轴突以及轴突终末含有甘氨酸免疫反应性。对半薄切片的光学显微镜观察表明,这些免疫反应性结构在整个核内分布不均匀。在电子显微镜水平上,通过定量分析方法,将具有高水平甘氨酸免疫反应性的突触终末(假定代表释放甘氨酸作为神经递质的终末)与含有低水平、可能是代谢水平甘氨酸免疫反应性的终末区分开来。该方法将随机采样的终末的免疫标记与从迷走神经背核神经元胞体采样得出的参考标记水平进行比较。这些“甘氨酸能”终末绝大多数含有多形性囊泡,形成对称的突触活性区,并以树突为靶点。它们在孤束核中与孤束相邻的区域似乎更多,但在尾侧、内侧、腹侧以及迷走神经背运动核中相当稀少。在对整个孤束核的随机分析中,发现26.2%的采样终末具有甘氨酸免疫反应性。相比之下,对γ-氨基丁酸(GABA)有免疫反应性的终扣在整个迷走神经复合体中分布更为均匀,占采样突触终末的33.7%。连续超薄切片的比较表明存在三种突触终末亚群:一种同时含有高水平的GABA和甘氨酸免疫反应性(占所有采样终末的21%),一种仅含有GABA免疫反应性(12.7%),以及相对较少的仅对甘氨酸有免疫反应性的终末(5.2%)。使用不同大小金颗粒对切片进行双重标记证实了这些结果。本研究首次分析了猫迷走神经复合体中甘氨酸能神经终末的超微结构,观察到的甘氨酸和GABA共存模式为我们先前报道的甘氨酸和GABA对孤束核中具有心血管和呼吸功能的神经元的抑制作用提供了解剖学解释。